ETFsXtrackers MSCI Europe Consumer Staples UCITS ETF 1C
Xtrackers
Xtrackers MSCI Europe Consumer Staples UCITS ETF 1C
DXSK XETRAAccumulatingLuxembourg
Last close · EUR
152.50EUR
+2.28% · +€3.40
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
DXSKBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +11.9%
- Sharpe 3Y
- -0.05
- Volatility 1Y
- 18.3%annualised
- Holdings
- 37Fund holdings
Performance
Compare
- DXSK+11.9%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| DXSK | +12.4% | +4.1% | +14.2% | +12.4% | +11.9% | +6.7% | -3.9% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.0% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +12.0% | -0.8% | +3.4% | -3.6% | -4.0% | -68.8% | -75.2% |
Risk and return
Sharpe ratio · 3Y
-0.05
Below MSCI World · 1.24- Return p.a.
- +0.9%
- Volatility
- 15.1%
- Max loss
- -17.1%Mar 2026
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
DXSK
-0.05
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 75.5%
- Holdings
- 37
- As of
- 1NESTLE SACH003886335021.29%
- 2UNILEVER PLCGB00BVZK7T9011.29%
- 3BRITISH AMERICAN TOBACCOGB00028758049.89%
- 4LOREAL SAFR00001203219.38%
- 5ANHEUSER-BUSCH INBEV SABE09742932515.80%
- 6DIAGEO PLCGB00023740064.21%
- 7DANONE SAFR00001206443.71%
- 8RECKITT BENCKISER GROUP PLCGB00BSZBP5303.70%
- 9TESCO PLCGB00BLGZ98623.64%
- 10KONINKLIJKE AHOLD DELHAIZENL00117940372.59%
Countries
Classified 100.0%
GB
Switzerland23.3%
France15.0%
BE
NL
DE
NO
- Largest
- 39.0%United Kingdom
- Top 3
- 77.3%
- Effective number
- 4.21 / HHI
Market cap
Weight vs holdings
75.5%of the fund sits in the top 10 holdings
75.5%24.5%
WeightHoldings
1027
- Holdings 1-10
- Holdings 11-37
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.